US$ 22.69
glp 1 api Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Frontiers | Revisiting food addiction
Description
These adverse effectsincluding nausea, vomiting, diarrhoea, constipation, and abdominal discomfortare dose-dependent and represent the most frequent reason for treatment discontinuation

Contact PAAS at (608) 873-1342, if you would like a tour of your PAAS Member Portal, so you can reap all the benefits of your PAAS Audit Assistance

First-line therapy for type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists : a cost-effectiveness study

J Clin Endocrinol Metab 90(4):19291935
